Luca Valenti

Citované v

	Všetky	Od 2020
Citácie	46453	33662
h-index	101	80
i10-index	330	290

10000

5000

2500

7500

2007200820092010201120122013201420152016201720182019202020212022202320242025158 247 283 388 627 751 837 937 1297 1555 1510 1597 1929 3852 6054 6431 6849 9169 1142

Verejný prístup

všetky položky

208 článkov

18 článkov

dostupné

nedostupné

Na základe mandátov na financovanie

Spoluautori

Anna Ludovica FRACANZANIDepartment of Pathophysiology and Transplantation, Fondazione Ca' Granda IRCCS Ospedale MaggioreOverená e-mailová adresa na: unimi.it
Stefano Romeo, ProfessorKarolinska InstitutetOverená e-mailová adresa na: ki.se
Salvatore PettaRicercatore di Gastroenterologia, Università di PalermoOverená e-mailová adresa na: unipa.it
Daniele PratiDirettore, Dipartimento di Medicina Trasfusionale e di Ematologia, Fondazione IRCCS Ca' GrandaOverená e-mailová adresa na: policlinico.mi.it
Luca MieleFondazione Pol. Univ. A. Gemelli IRCCS, Università Cattolica Sacro Cuore. RomaOverená e-mailová adresa na: policlinicogemelli.it
Guido BaselliPhD Student, Department of Pathophysiology and transplantation, University of MilanOverená e-mailová adresa na: unimi.it
Rosellina Margherita MancinaDepartment of Life Science, Health, and Health Professions, Link Campus UniversityOverená e-mailová adresa na: wlab.gu.se
Antonio CraxiFull Professor of Gastroenterology and Internal Medicine, PROMISE, University of Palermo, ItalyOverená e-mailová adresa na: unipa.it
Alessio AghemoHumanitas UniversityOverená e-mailová adresa na: hunimed.eu
Enrico GalmozziUniversità di MilanoOverená e-mailová adresa na: unimi.it
Giulio MarchesiniProfessor of Medicine, University of BolognaOverená e-mailová adresa na: unibo.it
Benedetta Maria MottaUniversità di SalernoOverená e-mailová adresa na: unisa.it
Massimiliano RuscicaUniversità degli Studi di MilanoOverená e-mailová adresa na: unimi.it
mozzi eUniversity of MilanOverená e-mailová adresa na: unimi.it
Piero PingitoreGothenburg UniversityOverená e-mailová adresa na: wlab.gu.se
Calogero CammàSection of Gastroenterology, University of PalermoOverená e-mailová adresa na: unipa.it
Stefano GattiFondazione IRCCS Ca' Granda Ospedale Maggiore PoliclinicoOverená e-mailová adresa na: unimi.it
Paolo MagniUniversità degli Studi di MilanoOverená e-mailová adresa na: unimi.it
Giovanni TargherFull Professor of Endocrinology and Diabetes, University of VeronaOverená e-mailová adresa na: univr.it
Miriam LongoGeneral and Internal MedicineOverená e-mailová adresa na: unimi.it

Sledovať

Luca Valenti

Associate Professor of Internal Medicine, Università degli Studi di Milano, Fondazione Ca' Granda

Overená e-mailová adresa na: unimi.it

internal medicine hepatology non-alcoholic fatty liver disease iron metabolism genetics


Názov Zoradiť podľa citácií Zoradiť podľa roka Zoradiť podľa názvu	Citované v Citované v	Rok
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement M Eslam, PN Newsome, SK Sarin, QM Anstee, G Targher, ... Journal of hepatology 73 (1), 202-209, 2020	3844	2020
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ... Gastroenterology 158 (7), 1999-2014. e1, 2020	3045	2020
A multisociety Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Hepatology 78 (6), 1966-1986, 2023	2982	2023
Genomewide association study of severe Covid-19 with respiratory failure Severe Covid-19 GWAS Group New England Journal of Medicine 383 (16), 1522-1534, 2020	2027	2020
Genetics and epigenetics of NAFLD and NASH: Clinical impact M Eslam, L Valenti, S Romeo Journal of hepatology 68 (2), 268-279, 2018	1019	2018
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes AL Fracanzani, L Valenti, E Bugianesi, M Andreoletti, A Colli, E Vanni, ... Hepatology 48 (3), 792-798, 2008	915	2008
Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021	838	2021
Homozygosity for the patatin‐like phospholipase‐3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease L Valenti, A Al‐Serri, AK Daly, E Galmozzi, R Rametta, P Dongiovanni, ... Hepatology 51 (4), 1209-1217, 2010	722	2010
Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes D Frescas, L Valenti, D Accili Journal of Biological Chemistry 280 (21), 20589-20595, 2005	693	2005
The MBOAT7-TMC4 variant rs641738 increases risk of nonalcoholic fatty liver disease in individuals of European descent RM Mancina, P Dongiovanni, S Petta, P Pingitore, M Meroni, R Rametta, ... Gastroenterology 150 (5), 1219-1230. e6, 2016	691	2016
Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease P Dongiovanni, S Petta, C Maglio, AL Fracanzani, R Pipitone, E Mozzi, ... Hepatology 61 (2), 506-514, 2015	608	2015
Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022	589	2022
Statin use and non-alcoholic steatohepatitis in at risk individuals P Dongiovanni, S Petta, V Mannisto, RM Mancina, R Pipitone, V Karja, ... Journal of hepatology 63 (3), 705-712, 2015	468	2015
Tumor necrosis factor α promoter polymorphisms and insulin resistance in nonalcoholic fatty liver disease L Valenti, AL Fracanzani, P Dongiovanni, G Santorelli, A Branchi, E Taioli, ... Gastroenterology 122 (2), 274-280, 2002	442	2002
Genome-wide association study of non-alcoholic fatty liver and steatohepatitis in a histologically characterised cohort☆ QM Anstee, R Darlay, S Cockell, M Meroni, O Govaere, D Tiniakos, ... Journal of hepatology 73 (3), 505-515, 2020	437	2020
COVID-19 and liver disease J Sun, A Aghemo, A Forner, L Valenti Liver international 40 (6), 1278-1281, 2020	430	2020
Iron in fatty liver and in the metabolic syndrome: a promising therapeutic target P Dongiovanni, AL Fracanzani, S Fargion, L Valenti Journal of hepatology 55 (4), 920-932, 2011	423	2011
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells C Pirazzi, L Valenti, BM Motta, P Pingitore, K Hedfalk, RM Mancina, ... Human molecular genetics 23 (15), 4077-4085, 2014	416	2014
Update on NAFLD genetics: from new variants to the clinic E Trépo, L Valenti Journal of hepatology 72 (6), 1196-1209, 2020	361	2020
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study L Valenti, AL Fracanzani, P Dongiovanni, E Bugianesi, G Marchesini, ... Official journal of the American College of Gastroenterology\| ACG 102 (6 …, 2007	360	2007

Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.

Články 1–20

Citácie za rok

Duplicitné citácie

Zlúčené citácie

Pridať spoluautorovSpoluautori

Sledovať

Citované v

Spoluautori